4//SEC Filing
Osborne Matthew Scott 4
Accession 0001209191-20-009293
CIK 0001622229other
Filed
Feb 12, 7:00 PM ET
Accepted
Feb 13, 4:55 PM ET
Size
5.6 KB
Accession
0001209191-20-009293
Insider Transaction Report
Form 4
Osborne Matthew Scott
Chief Financial Officer
Transactions
- Award
Stock Option
2020-02-11+160,400→ 160,400 totalExercise: $0.80Exp: 2030-02-11→ Common Stock (160,400 underlying)
Footnotes (1)
- [F1]25% of the shares vests on February 11, 2021, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Persons continuous service with the Issuer.
Documents
Issuer
Unum Therapeutics Inc.
CIK 0001622229
Entity typeother
Related Parties
1- filerCIK 0001780543
Filing Metadata
- Form type
- 4
- Filed
- Feb 12, 7:00 PM ET
- Accepted
- Feb 13, 4:55 PM ET
- Size
- 5.6 KB